-
Je něco špatně v tomto záznamu ?
Intravenous insulin therapy during lung resection does not affect lung function or surfactant proteins
Z. Ručka, I. Koutná, L. Tesařová, M. Potěšilová, S. Stejskal, P. Simara, P. Vaňhara, J. DoleŽel, V. Zvoníček, O. Coufal, I. Capov,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, randomizované kontrolované studie, práce podpořená grantem
NLK
BioMedCentral
od 2001-12-01
BioMedCentral Open Access
od 2001
Directory of Open Access Journals
od 2001
Free Medical Journals
od 2001
PubMed Central
od 2001
Europe PubMed Central
od 2001
ProQuest Central
od 2009-01-01
Open Access Digital Library
od 2001-09-01
Open Access Digital Library
od 2001-01-01
Open Access Digital Library
od 2001-01-01
Medline Complete (EBSCOhost)
od 2001-01-01
Health & Medicine (ProQuest)
od 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2001
Springer Nature OA/Free Journals
od 2001-12-01
PubMed
25278226
DOI
10.1186/1471-2466-14-155
Knihovny.cz E-zdroje
- MeSH
- analýza krevních plynů MeSH
- časové faktory MeSH
- dospělí MeSH
- exprese genu účinky léků MeSH
- hydrogenuhličitany krev MeSH
- hyperglykemie farmakoterapie etiologie MeSH
- hypoglykemika aplikace a dávkování MeSH
- intravenózní podání MeSH
- inzulin aplikace a dávkování MeSH
- koncentrace vodíkových iontů MeSH
- krevní glukóza účinky léků MeSH
- kyslík krev MeSH
- lidé středního věku MeSH
- lidé MeSH
- messenger RNA metabolismus MeSH
- nádory plic chirurgie MeSH
- oxid uhličitý krev MeSH
- plíce účinky léků patofyziologie MeSH
- pneumektomie škodlivé účinky MeSH
- poruchy acidobazické rovnováhy MeSH
- prospektivní studie MeSH
- proteiny asociované s plicním surfaktantem genetika MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- randomizované kontrolované studie MeSH
BACKGROUND: The surgical resection of lung disrupts glucose homeostasis and causes hyperglycemia, as in any other major surgery or critical illness. We performed a prospective study where we carefully lowered hyperglycemia by insulin administration during the surgery, and for the first time we monitored immediate insulin effects on lung physiology and gene transcription. METHODS: The levels of blood gases (pH, pCO2, pO2, HCO3-, HCO3- std, base excess, FiO2, and pO2/FiO2) were measured at the beginning of surgery, at the end of surgery, and two hours after. Samples of healthy lung tissue surrounding the tumour were obtained during the surgery, anonymized and sent for subsequent blinded qPCR analysis (mRNA levels of surfactant proteins A1, A2, B, C and D were measured). This study was done on a cohort of 64 patients who underwent lung resection. Patients were randomly divided, and half of them received insulin treatment during the surgery. RESULTS: We demonstrated for the first time that insulin administered intravenously during lung resection does not affect levels of blood gases. Furthermore, it does not induce immediate changes in the expression of surfactant proteins. CONCLUSION: According to our observations, short insulin treatment applied intravenously during resection does not affect the quality of breathing.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15022983
- 003
- CZ-PrNML
- 005
- 20150729111218.0
- 007
- ta
- 008
- 150709s2014 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/1471-2466-14-155 $2 doi
- 035 __
- $a (PubMed)25278226
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Ručka, Zdenek
- 245 10
- $a Intravenous insulin therapy during lung resection does not affect lung function or surfactant proteins / $c Z. Ručka, I. Koutná, L. Tesařová, M. Potěšilová, S. Stejskal, P. Simara, P. Vaňhara, J. DoleŽel, V. Zvoníček, O. Coufal, I. Capov,
- 520 9_
- $a BACKGROUND: The surgical resection of lung disrupts glucose homeostasis and causes hyperglycemia, as in any other major surgery or critical illness. We performed a prospective study where we carefully lowered hyperglycemia by insulin administration during the surgery, and for the first time we monitored immediate insulin effects on lung physiology and gene transcription. METHODS: The levels of blood gases (pH, pCO2, pO2, HCO3-, HCO3- std, base excess, FiO2, and pO2/FiO2) were measured at the beginning of surgery, at the end of surgery, and two hours after. Samples of healthy lung tissue surrounding the tumour were obtained during the surgery, anonymized and sent for subsequent blinded qPCR analysis (mRNA levels of surfactant proteins A1, A2, B, C and D were measured). This study was done on a cohort of 64 patients who underwent lung resection. Patients were randomly divided, and half of them received insulin treatment during the surgery. RESULTS: We demonstrated for the first time that insulin administered intravenously during lung resection does not affect levels of blood gases. Furthermore, it does not induce immediate changes in the expression of surfactant proteins. CONCLUSION: According to our observations, short insulin treatment applied intravenously during resection does not affect the quality of breathing.
- 650 _2
- $a poruchy acidobazické rovnováhy $7 D000137
- 650 _2
- $a intravenózní podání $7 D061605
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a hydrogenuhličitany $x krev $7 D001639
- 650 _2
- $a analýza krevních plynů $7 D001784
- 650 _2
- $a krevní glukóza $x účinky léků $7 D001786
- 650 _2
- $a oxid uhličitý $x krev $7 D002245
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a exprese genu $x účinky léků $7 D015870
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a koncentrace vodíkových iontů $7 D006863
- 650 _2
- $a hyperglykemie $x farmakoterapie $x etiologie $7 D006943
- 650 _2
- $a hypoglykemika $x aplikace a dávkování $7 D007004
- 650 _2
- $a inzulin $x aplikace a dávkování $7 D007328
- 650 _2
- $a plíce $x účinky léků $x patofyziologie $7 D008168
- 650 _2
- $a nádory plic $x chirurgie $7 D008175
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a kyslík $x krev $7 D010100
- 650 _2
- $a pneumektomie $x škodlivé účinky $7 D011013
- 650 _2
- $a prospektivní studie $7 D011446
- 650 _2
- $a proteiny asociované s plicním surfaktantem $x genetika $7 D037661
- 650 _2
- $a messenger RNA $x metabolismus $7 D012333
- 650 _2
- $a časové faktory $7 D013997
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a randomizované kontrolované studie $7 D016449
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Koutná, Irena $u Masaryk University, Faculty of Informatics, Centre for Biomedical Image Analysis, Botanická 68a, 60200 Brno, Czech Republic. qkoutna@fi.muni.cz.
- 700 1_
- $a Tesařová, Lenka
- 700 1_
- $a Potěšilová, Michaela
- 700 1_
- $a Stejskal, Stanislav
- 700 1_
- $a Simara, Pavel
- 700 1_
- $a Vaňhara, Petr
- 700 1_
- $a DoleŽel, Jan
- 700 1_
- $a Zvoníček, Vaclav
- 700 1_
- $a Coufal, Oldřich
- 700 1_
- $a Capov, Ivan
- 773 0_
- $w MED00008206 $t BMC pulmonary medicine $x 1471-2466 $g Roč. 14, č. - (2014), s. 155
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25278226 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150709 $b ABA008
- 991 __
- $a 20150729111305 $b ABA008
- 999 __
- $a ok $b bmc $g 1083322 $s 905976
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 14 $c - $d 155 $i 1471-2466 $m BMC pulmonary medicine $n BMC Pulm Med $x MED00008206
- LZP __
- $a Pubmed-20150709